Has Leopoldo Grauer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,268 in general payments to Leopoldo Grauer, MD across 106 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leopoldo Grauer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leopoldo Grauer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leopoldo Grauer, MD

Gastroenterology · Tampa, FLNPI 1750377834

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 32.3% of the total.

$4,268in general payments, 2019–2025

Across 106 payments — averaging $40.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$308
Ambu Inc.$306
Intercept Pharmaceuticals, Inc.$304
Janssen Scientific Affairs, LLC$241
Sanofi$213
plus $2K from 18 others

$45,477in research payments, 2019–2025

Across 1 payment — averaging $45,477 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$45K

What the payments were for

Food & beverage$4,260100%
Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	36	$1,378
Johnson & Johnson(2 entities)	6	$308
Ambu Inc.	3	$306
Intercept Pharmaceuticals, Inc.	5	$304
Janssen Scientific Affairs, LLC	2	$241
Sanofi	2	$213
Evoke Pharma, Inc.	16	$205
Boston Scientific	2	$177
Merck	4	$154
Ferring Pharmaceuticals Inc.	1	$122
E.r. Squibb & Sons, L.L.C.	1	$122
Madrigal Pharmaceuticals	4	$104
UCB, Inc.	2	$98
QOL Medical, LLC	3	$89
Lucid Diagnostics Inc.	2	$88
Gilead	2	$74
Ardelyx, Inc.	3	$66
Bristol Myers Squibb	4	$57
Intuitive Surgical	1	$50
Fujifilm Healthcare Americas Corporation	2	$38
Takeda Pharmaceuticals U.S.A., Inc.	2	$29
Aimmune Therapeutics, Inc.	1	$15
Phathom Pharmaceuticals, Inc.	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$365
STELARA$359
OCALIVA$250
Rinvoq$125
Creon$124
REBYOTA$122
AXIOS$115
DUPIXENT$114

How this compares

$4,268 in reported general payments places this provider in the 55th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024

$14,240

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	41	$280
Dicyclomine Hcl	12	$203
Omeprazole	18	$73
Metoclopramide Hcl	20	$49

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Tampa

Adnan MuhammadTampa$150K
John JacobsTampa$141K
Renee Marchioni BeeryTampa$126K
Michael DanielTampa$52K
Samuel GidayOrlando$2M
Lukasz KwapiszMiami$1.2M
Jennifer Seminerio-DiehlOrlando$1.1M
Udayakumar NavaneethanSaint Petersburg$1.1M
Ronen AraiCoral Springs$1.1M
Charles SninskyGainesville$983K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →